Cleared Traditional

K250651 - OptiPAP Junior Flexi Tube US (OPTIPAPFUS) (FDA 510(k) Clearance)

Also includes:
OptiPAP Junior Nasal Prongs XXS (OPTIPAPPXXS) OptiPAP Junior Nasal Prongs XS (OPTIPAPPXS) OptiPAP Junior Nasal Prongs S (OPTIPAPPS) OptiPAP Junior Nasal Prongs M (OPTIPAPPM) OptiPAP Junior Nasal Prongs L (OPTIPAPPL) OptiPAP Junior Nasal Prongs XL (OPTIPAPPXL) OptiPAP Junior Nasal Mask XXS (OPTIPAPMXXS) OptiPAP Junior Nasal Mask XS (OPTIPAPMXS) OptiPAP Junior Nasal Mask S (OPTIPAPMS) OptiPAP Junior Nasal Mask M (OPTIPAPMM) OptiPAP Jun
Nov 2025
Decision
260d
Days
Class 2
Risk

K250651 is an FDA 510(k) clearance for the OptiPAP Junior Flexi Tube US (OPTIPAPFUS). This device is classified as a Noninvasive Positive Airway Pressure System, Facility Use (Class II - Special Controls, product code SGR).

Submitted by Fisher &Paykel Healthcare , Ltd. (Auckland, NZ). The FDA issued a Cleared decision on November 19, 2025, 260 days after receiving the submission on March 4, 2025.

This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 868.5895. To Mechanically Assist Patient Breathing By Delivering A Predetermined Percentage Of Oxygen In The Breathing Gas Through Noninvasive Continuous Positive Airway Pressure..

Submission Details

510(k) Number K250651 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 04, 2025
Decision Date November 19, 2025
Days to Decision 260 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code SGR — Noninvasive Positive Airway Pressure System, Facility Use
Device Class Class II - Special Controls
CFR Regulation 21 CFR 868.5895
Definition To Mechanically Assist Patient Breathing By Delivering A Predetermined Percentage Of Oxygen In The Breathing Gas Through Noninvasive Continuous Positive Airway Pressure.